Log in or Sign up for Free to view tailored content for your specialty!
Osteoarthritis and Bone Disorders News
Duration of knee, hip OA may increase cardiovascular mortality
LIVERPOOL, England — Prolonged knee and hip osteoarthritis, but not hand osteoarthritis, were associated with increased cardiovascular mortality, according to findings presented here.
Hip pain shows modest association with mortality
LIVERPOOL, England — Hip pain demonstrated mild associations with both all-cause and cardiovascular-specific mortality in an analysis of community-based participants from the Johnston County cohort, according to findings presented here.
Log in or Sign up for Free to view tailored content for your specialty!
OARSI Keynote: Understanding human behavior improves patient outcomes
LIVERPOOL, England — Understanding the incentives that drive human behavior may be useful in helping patients with osteoarthritis improve health-related habits, according to keynote speaker David Asch, MD.
Targeting physical activity, depression could reduce mortality in OA
LIVERPOOL, England — Low walking frequency and depression were associated with an increase in mortality in patients with osteoarthritis, according to findings presented here.
Concerns remain over OA-related morbidity, mortality after OARSI white paper
LIVERPOOL, England — Two authors of the 2016 OARSI White Paper outlined key data that led to the FDA’s acceptance of osteoarthritis as a serious disease and laid out future challenges for clinicians managing the disease during the OARSI World Congress on Osteoarthritis.
OARSI president addresses future of OA, achievement awards
LIVERPOOL, England — With nearly half of OARSI members younger than 40 years, the future of the organization is bright, according to president Jeffrey Katz, MD, MSc.
FDA advisory committees back CV safety of Celebrex for OA, RA
During a joint meeting of the FDA Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee, members voted 15 to 5 that the cardiovascular risk of celecoxib was no worse than the risk associated with naproxen or ibuprofen among patients with osteoarthritis or rheumatoid arthritis.
Study highlights age-related trends in prevalence of arthritis from 1999 to 2014
Nearly 25% of U.S. adults between 1999 and 2014 reported having arthritis, according to a recently published study in the American Journal of Public Health. Investigators found the prevalence of osteoarthritis doubled with time and the prevalence of rheumatoid arthritis decreased during the study period.
Denosumab more effective than risedronate in glucocorticoid-induced osteoporosis
Adults with a history of glucocorticoid-induced osteoporosis assigned to therapy with the monoclonal antibody denosumab experienced a greater increase in bone mineral density at the lumber spine and total hip at 12 months vs. similar patients assigned the bisphosphonate risedronate, according to findings from a global, randomized, active-controlled trial.
Younger age linked to improved OA knee pain after bariatric surgery
Patients with knee osteoarthritis who were younger, as well as those without prior knee injury, at the time they underwent laparoscopic gastric band surgery reported more pain relief following the procedure, according to findings published in Seminars in Arthritis and Rheumatism.